Neprilysin
(Homo sapiens (Human)) | BDBM300293
(US9593110, 21-7)Show SMILES NC[C@H](C[C@@H](Cc1ccc(cc1)-c1cc(Cl)ccc1F)NC(=O)c1cnsc1)C(O)=O Show InChI InChI=1S/C22H21ClFN3O3S/c23-17-5-6-20(24)19(9-17)14-3-1-13(2-4-14)7-18(8-15(10-25)22(29)30)27-21(28)16-11-26-31-12-16/h1-6,9,11-12,15,18H,7-8,10,25H2,(H,27,28)(H,29,30)/t15-,18+/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| 2.20 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Theravence Biopharma R&D IP, LLC
US Patent
| Assay Description Recombinant human NEP and recombinant human ACE were obtained commercially (R&D Systems, Minneapolis, Minn., catalog numbers 1182-ZN and 929-ZN, resp... |
US Patent US9593110 (2017)
BindingDB Entry DOI: 10.7270/Q2MC9224 |